Lixte Biotechnology Holdings Inc Warrants (01/01/2025) LIXTW 深 滬
已收盤 10-24 16:00:00 美东时间
0.1265
-0.039
-23.61%
華盛通- 最 高0.18
- 今 開0.1656
- 成交量 2.16万股
- 最 低 0.1265
- 昨 收 0.1656
- 總市值 171.26万
- 52周最高 0.38
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.02
- 委 比 69.28%
- 總股本 1353.83万
- 歷史最高 6.77
- 量 比 3.11
- 振 幅 32.31%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Genprex (NASDAQ:GNPX) stock increased by 88.1% to $0.47 during Wednesd...
10-15 20:09
Lixte Biotechnology Invests $2.6M in Cryptocurrencies
The latest announcement is out from Lixte Biotechnology Holdings ( ($LIXT) ). O...
09-12 01:47
LIXTE Biotechnology makes $2.6M initial purchase of digital currency
LIXTE Biotechnology (NASDAQ:LIXT) said on Wednesday that it has made an initial purchase of cryptocurrencies to further diversify its treasury holdings and for potential acquisitions. The company purc...
09-11 04:17
Lixte Biotechnology appoints new CFO and board members
Lixte Biotechnology (NASDAQ:LIXT) appointed Peter Stazzone as chief financial officer. Lourdes Felix and Guy Primus joined LIXTE’s board of directors. Former CFO Robert Weingarten and board members Ba...
09-03 20:18
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising
The latest announcement is out from Lixte Biotechnology Holdings ( ($LIXT) ). O...
07-17 04:47
LIXTE Biotechnology regains Nasdaq compliance
LIXTE Biotechnology (NASDAQ:LIXT) announced on Wednesday it has received a Nasdaq letter, stating that the company has regained compliance with Nasdaq’s Listing Rule, requiring a minimum equity requir...
07-16 20:34
Lixte Biotechnology Closes $1.5M Direct Offering
Lixte Biotechnology Holdings ( ($LIXT) ) has issued an update. On July 8, 2025,...
07-09 05:47
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 171.6% to $27....
07-07 20:07
Lixte Biotechnology Announces $5M Private Placement
Lixte Biotechnology Holdings ( ($LIXT) ) has provided an update. On July 1, 202...
07-03 18:28
Lixte Biotechnology Raises ~$5M Through Sale Of 2.38M Common Shares, 3.57M Preferred Shares, and 6.36M Warrants
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) (the "Company"), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with accredited investors
07-02 04:19
